Rajat Malhotra MD in Arlington Heights, Illinois

Home Illinois Arlington Heights

Rajat Malhotra MD has Hematology/oncology as his primary medical specialty. Their primary office is: 880 W Central Rd in Arlington Heights, Illinois.

They're a part of the: Illinois Cancer Specialists medical group which has around 31 members. You can call their office at 847-259-4482 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Southern Illinois University School Of Medicine and graduated in 1994 (around 30 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Rajat Malhotra MD Office Phone and Directions

Rajat Malhotra MD
Illinois Cancer Specialists
880 W Central Rd
Arlington Heights, Illinois 60005
847-259-4482

Patient Ratings
Please rate your experience with Rajat Malhotra MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 847-259-4482

Enter a starting address:

Healthcare Info for Rajat Malhotra MD

Medical School: Southern Illinois University School Of Medicine
Graduation Year: 1994
The Primary Medical Specialty for Rajat Malhotra MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 30
PAC (PECOS ID)#: 8123083094
NPI #: 1982693370
NPI Created On: 10/18/2005
NPI Last Updated Listed as: 10/10/2013
Primary Taxonomy Code: 207RH0003X
License Number:
036095434
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Complete blood cell count (red cells, white blood cell, platelets), automated test
Blood test, clotting time
Flow cytometry technique for dna or cell analysis
Flow cytometry technique for dna or cell analysis
Vaccine for influenza for administration into muscle, 0.5 ml dosage
Hydration infusion into a vein 31 minutes to 1 hour
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of drug or substance into a vein for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788891533

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $1,400

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 782607839

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CINV

Name of Drug #1: SUSTOL

Open Associated Drug #1: 47426-101-01

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781012635

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781012639

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $95

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781012637

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795460765

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818688583

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818719197

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801706043

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: ZEJULA

Open Associated Drug #1: 69656-103-90

Payments Total: $15

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783536959

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Hematology/oncology Professionals in Arlington Heights

1.
Asadullah Khan MD

800 W Central Rd
Arlington-heights, IL
North Shore University Healthsystem Faculty Practice Associates

2.
Randy Rich MD

880 W Central Rd
Arlington-heights, IL
Illinois Cancer Specialists

3.
Fatema Esmail

880 W Central Rd
Arlington-heights, IL
Illinois Cancer Specialists

4.
Richard Siegel

880 W Central Rd
Arlington-heights, IL
Illinois Cancer Specialists

5.
Urszula Sobol

880 W Central Rd
Arlington-heights, IL
Illinois Cancer Specialists

Providers in Illinois Cancer Specialists

1.Zachary Andor

1710 N Randall Rd
Elgin Il 60123-9405
Illinois Cancer Specialists
Physician Assistant

2.Zachary Andor

8915 W Golf Rd
Niles Il 60714-5905
Illinois Cancer Specialists
Physician Assistant

3.Lisa Baddi Do

7447 W Talcott Ave
Chicago Il 60631-3712
Illinois Cancer Specialists
Hematology/oncology

4.Sonia Christian

8915 W Golf Rd
Niles Il 60714-5905
Illinois Cancer Specialists
Hematology/oncology

5.Bety Ciobanu

7447 W Talcott Ave
Chicago Il 60631-3712
Illinois Cancer Specialists
Internal Medicine

6.Bety Ciobanu

8915 W Golf Rd
Niles Il 60714-5905
Illinois Cancer Specialists
Internal Medicine

View all 31 members of Illinois Cancer Specialists medical group